Carbiotix signs collaboration agreement with academic partner focused on neuroinflammation
Carbiotix (publ) ("Carbiotix") announces today that the company has signed a collaboration agreement with the Department of Medicine at the University of Verona, Italy, to carry out a research study during H1 2020 in the area of neuroinflammation using Carbiotix Microbiome Modulator Therapeutics. The collaboration agreement will seek to find new applications and further validate Carbiotix platform.The in-vivo research study to be conducted in H1 2020 will be led by Dr. Elena Zenaro, a researcher at the Department of Medicine, General Pathology Section, at the University of Verona, Italy.